News
 

People with type 2 diabetes face a heightened risk of Alzheimer's disease and cognitive decline. A study by Umeå University in Sweden suggests this may be due to their reduced ability to eliminate beta-amyloids—proteins linked to Alzheimer's—from the brain.

A recent review in Nutrients highlights saffron's potential in preventing and treating various diseases. Saffron, derived from Crocus sativus L., is known for its health benefits, including antimicrobial, anti-inflammatory, and antioxidant properties.

A new study uncovers the different patterns and reasons behind procrastination using a mathematical framework. It shows that procrastination is influenced by factors like immediate rewards and uncertainty about future outcomes.

Researchers at Queen Mary University of London have developed a new method for predicting dementia with over 80% accuracy, up to nine years before diagnosis. This method surpasses traditional memory tests and brain shrinkage measurements. Led by Professor Charles Marshall, the team used functional MRI (fMRI) scans to analyze changes in the brain's...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, commonly diagnosed in individuals aged 20 to 40. It leads to cognitive and physical impairments, including coordination issues, paralysis, sensory disturbances, and vision problems. MS is classified into subtypes like clinically isolated syndrome,...

A new study finds that urolithin A, a substance found in pomegranates, can improve memory and may help treat Alzheimer's disease. This natural compound works by removing damaged mitochondria from the brain, similar to the effects of NAD supplements. While dosage is still being determined, this discovery offers promising potential for treating and...